BABeyza Akyüz

Beyza Akyüz

*This is an algorithmically generated author record based on publicly available information.

Beyza Akyüz has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • DEVELOPMENT AND IN-VITRO EVALUATION OF MUCOADHESIVE BUCCAL NANOFIBER FORMULATIONS FOR USE IN ORAL ULCER TREATMENT

    by Beyza Akyüz, Sinem Saar, Fatma Nur Tuğcu Demiröz

    Objective: Oral ulcers are common lesions that negatively affect patients’ quality of life due to pain, inflammation, and discomfort. The aim of this study was to develop and evaluate mucoadhesive nanofiber formulations containing hydrocortisone (HC) for the local treatment of oral ulcers. Material and Method: Different types of Eudragit (E100, S100, L100-55) and polyvinylpyrrolidone (PVP) were used as mucoadhesive polymers. Nanofibers were fabricated using electrospinning system. Nanofibers characterized by differential scanning calorimetry (DSC), mechanical testing, contact angle measurements, and ex vivo mucoadhesion studies for buccal application. Result and Discussion: Nanofibers were successfully produced with electrospinning. Thermal analyses confirmed the HC within the nanofibers. Mechanical and wettability studies showed that the nanofibers had suitable physical properties for buccal application. In ex vivo mucoadhesion tests of the formulations, values were 0.20 ± 0.05, 0.12 ± 0.03, and 0.14 ± 0.01 mJ cm⁻² for E2-HC, L2-HC, and S2-HC, respectively. Mucoadhesion tests demonstrated strong adhesion to the mucosal surface, indicating potential for extended residence time and effective local drug delivery. In vitro release profiles of formulations, HC released 40.26%, 47.87% and 47.03% at 1 h for E2-HC, L2-HC and S2-HC, respectively. The formulations demonstrated sustained release and favorable mucoadhesive strength, indicating potential clinical applicability. Hydrocortisone-loaded buccal electrospun nanofibers showed promise as a novel and effective drug delivery platform in the treatment of oral ulcers.

  • HYDROCORTISONE-LOADED POLYVINYL ALCOHOL-BASED FILMS FOR BUCCAL DELIVERY IN THE TREATMENT OF ORAL APHTHOUS ULCERS

    by Beyza Akyüz, Sinem Saar, Fatma Nur Tuğcu Demiröz

    Oral aphthous ulcers are recurrent, painful lesions of the oral mucosa that adversely affect patients' quality of life. Buccal films are crucial to enhance drug retention, achieve sustained therapeutic effect, and ultimately improve clinical outcomes in patients suffering from oral aphthous ulcers. The aim of this study was to develop and evaluate polyvinyl alcohol (PVA)-based buccal film formulations loaded with hydrocortisone (HC) for the local treatment of oral aphthous ulcers. Buccal films were prepared using the solvent casting method. The film formulations were characterized in terms of film thickness, moisture content, and contact angle. Mechanical properties were evaluated by determining tensile strength and elongation at break using a texture analyzer. Thermal behavior was assessed via differential scanning calorimetry (DSC), while chemical interactions were examined using Fourier-transform infrared spectroscopy (FTIR). Mucoadhesive performance was tested ex vivo using cow buccal mucosa, and in vitro drug release studies were conducted using Franz diffusion cells with phosphate buffer (pH 6.8) as the receptor medium. The PVA-based formulation exhibited suitable mechanical strength and high elongation at break. Ex vivo mucoadhesion studies showed that the films demonstrated adequate mucoadhesive properties in cow buccal tissue. In vitro release studies demonstrated a sustained release profile of HC over 8 hours. The findings indicate that PVA-based buccal films are promising candidates for effective localized therapy of oral aphthous ulcers, enhanced patient compliance.